Fueling autoimmunity: type I interferon in autoimmune diseases

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Expert Review of Clinical Immunology

• Publication date

  2013-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1586/eci.12.106PMID 23445195PMCID PMC3873736
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tolerogenic function of Blimp-1 in dendritic cells

  2012cited by this paper
• Neutrophil function: from mechanisms to disease.

  2012cited by this paper
• IFN-α enhances cross-presentation in human dendritic cells by modulating antigen survival, endocytic routing, and processing.

  2012cited by this paper
• Clinical and serological manifestations associated with interferon-α levels in childhood-onset systemic lupus erythematosus

  2012cited by this paper
• Autoimmunity initiates in nonhematopoietic cells and progresses via lymphocytes in an interferon-dependent autoimmune disease.

  2012cited by this paper
• Plasmacytoid dendritic cells control T-cell response to chronic viral infection

  2012cited by this paper
• Ifih1 Gene Dose Effect Reveals MDA5-Mediated Chronic Type I IFN Gene Signature, Viral Resistance, and Accelerated Autoimmunity

  2012cited by this paper
• Neutrophil extracellular traps mediate transfer of cytoplasmic neutrophil antigens to myeloid dendritic cells toward ANCA induction and associated autoimmunity.

  2012cited by this paper
• Modulation of T‐cell function by type I interferon

  2012cited by this paper
• STING manifests self DNA-dependent inflammatory disease

  2012cited by this paper
• Molecular Characterization of Circulating Plasma Cells in Patients with Active Systemic Lupus Erythematosus

  2012cited by this paper
• Intrinsic antiviral immunity

  2012cited by this paper
• Serum from patients with SLE instructs monocytes to promote IgG and IgA plasmablast differentiation

  2012cited by this paper
• Nucleic acid-containing amyloid fibrils potently induce type I interferon and stimulate systemic autoimmunity

  2012cited by this paper
• B-cell depletion in the treatment of lupus nephritis

  2012cited by this paper
• Nucleic acid sensing at the interface between innate and adaptive immunity in vaccination

  2012cited by this paper
• Type I IFN Drives a Distinctive Dendritic Cell Maturation Phenotype That Allows Continued Class II MHC Synthesis and Antigen Processing

  2012cited by this paper
• Immunomodulatory functions of type I interferons

  2012cited by this paper
• Lupus neutrophils: ‘NET’ gain in understanding lupus pathogenesis

  2012cited by this paper
• NADPH Oxidase Inhibits the Pathogenesis of Systemic Lupus Erythematosus

  2012cited by this paper
• Active Immunization Against IFNα with IFN-Kinoid in SLE Patients Is Safe, Immunogenic and Induces Down-Regulation of IFN-Mediated Genes

  2011cited by this paper
• Interferon‐α induces unabated production of short‐lived plasma cells in pre‐autoimmune lupus‐prone (NZB×NZW)F1 mice but not in BALB/c mice

  2011cited by this paper
• Association of endogenous anti-interferon-α autoantibodies with decreased interferon-pathway and disease activity in patients with systemic lupus erythematosus.

  2011cited by this paper
• The ubiquitin-editing protein A20 prevents dendritic cell activation, recognition of apoptotic cells, and systemic autoimmunity.

  2011cited by this paper
• Interferon regulatory factors in human lupus pathogenesis.

  2011cited by this paper
• Netting Neutrophils Are Major Inducers of Type I IFN Production in Pediatric Systemic Lupus Erythematosus

  2011cited by this paper
• Murine Models of Systemic Lupus Erythematosus

  2011cited by this paper
• Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway

  2011cited by this paper
• Induction by Lupus Immune Complexes Differentially Regulate Inflammatory Gene Plasmacytoid Dendritic Cells and C1q

  2011cited by this paper
• Neutrophils Activate Plasmacytoid Dendritic Cells by Releasing Self-DNA–Peptide Complexes in Systemic Lupus Erythematosus

  2011cited by this paper
• Are autoantibodies the targets of B-cell-directed therapy?

  2011cited by this paper
• Genetic deficiency of tartrate-resistant acid phosphatase associated with skeletal dysplasia, cerebral calcifications and autoimmunity

  2011cited by this paper
• Binding with Nucleic Acids or Glycosaminoglycans Converts Soluble Protein Oligomers to Amyloid*

  2011cited by this paper
• Health care provision for osteoarthritis: Concordance between what patients would like and what health professionals think they should have

  2011cited by this paper
• Molecular Mimicry as a Mechanism of Autoimmune Disease

  2011cited by this paper
• Inflammatory Cytokines in Systemic Lupus Erythematosus

  2011cited by this paper
• Safety profile and clinical activity of sifalimumab, a fully human anti-interferon α monoclonal antibody, in systemic lupus erythematosus: a phase I, multicentre, double-blind randomised study

  2011cited by this paper
• Interferon Alpha as a Primary Pathogenic Factor in Human Lupus

  2011cited by this paper
• Type I interferon pathway in adult and juvenile dermatomyositis

  2011cited by this paper
• Cellular and molecular pathogenesis of systemic lupus erythematosus: lessons from animal models

  2011cited by this paper
• Genomics and the multifactorial nature of human autoimmune disease.

  2011cited by this paper
• Risk Alleles for Systemic Lupus Erythematosus in a Large Case-Control Collection and Associations with Clinical Subphenotypes

  2011cited by this paper
• HMGB1 is a therapeutic target for sterile inflammation and infection.

  2011cited by this paper
• IFN-α Production by Plasmacytoid Dendritic Cells Stimulated with RNA-Containing Immune Complexes Is Promoted by NK Cells via MIP-1β and LFA-1

  2011cited by this paper
• Type I interferonopathies: a novel set of inborn errors of immunity

  2011cited by this paper
• Telomere dysfunction, autoimmunity and aging.

  2011cited by this paper
• Protein folding: The dark side of proteins

  2010cited by this paper
• C1q Deficiency Leads to the Defective Suppression of IFN-α in Response to Nucleoprotein Containing Immune Complexes

  2010cited by this paper
• Immunodeficiency secondary to anticytokine autoantibodies

  2010cited by this paper
• Autoimmune skin inflammation is dependent on plasmacytoid dendritic cell activation by nucleic acids via TLR7 and TLR9

  2010cited by this paper
• Genetics of SLE: evidence from mouse models

  2010cited by this paper
• Sex-specific association of X-linked Toll-like receptor 7 (TLR7) with male systemic lupus erythematosus

  2010cited by this paper
• Lesional and nonlesional skin from patients with untreated juvenile dermatomyositis displays increased numbers of mast cells and mature plasmacytoid dendritic cells.

  2010cited by this paper
• Type I interferon system activation and association with disease manifestations in systemic sclerosis

  2010cited by this paper
• Protein-DNA Interaction at the Origin of Neurological Diseases: A Hypothesis

  2010cited by this paper
• Plasmacytoid dendritic cell ablation impacts early interferon responses and antiviral NK and CD8(+) T cell accrual.

  2010cited by this paper
• TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus

  2010cited by this paper
• Type I interferon in organ-targeted autoimmune and inflammatory diseases

  2010cited by this paper
• A Distinct Subset of Proinflammatory Neutrophils Isolated from Patients with Systemic Lupus Erythematosus Induces Vascular Damage and Synthesizes Type I IFNs

  2010cited by this paper
• Tartrate resistant acid phosphatase deficiency causes a bone dysplasia with autoimmunity and a type I interferon expression signature

  2010cited by this paper
• An Interferon-Inducible Neutrophil-Driven Blood Transcriptional Signature in Human Tuberculosis

  2010cited by this paper
• Amyloidosis.

  2009cited by this paper
• Cracking the BAFF code

  2009cited by this paper
• Type I interferon modulates monocyte recruitment and maturation in chronic inflammation.

  2009cited by this paper
• Induction of autoimmunity by pristane and other naturally occurring hydrocarbons.

  2009cited by this paper
• Type I interferon signaling in dendritic cells stimulates the development of lymph-node-resident T follicular helper cells.

  2009cited by this paper
• Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant

  2009cited by this paper
• In Brief

  2009cited by this paper
• Type I interferon and lupus

  2009cited by this paper
• Insights into the genetic basis and immunopathogenesis of systemic lupus erythematosus from the study of mouse models.

  2009cited by this paper
• Chapter 1 Amyloidosis

  2009cited by this paper
• Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases

  2009cited by this paper
• Regulation of the interferon-alpha production induced by RNA-containing immune complexes in plasmacytoid dendritic cells.

  2009cited by this paper
• Functional Amyloids Signal Their Arrival

  2009cited by this paper
• Interferon-alpha controls IL-17 expression in vitro and in vivo.

  2008cited by this paper
• TLR7-dependent and FcγR-independent production of type I interferon in experimental mouse lupus

  2008cited by this paper
• Systemic IFN‐α drives kidney nephritis in B6.Sle123 mice

  2008cited by this paper
• Induction of inflammatory and immune responses by HMGB1–nucleosome complexes: implications for the pathogenesis of SLE

  2008cited by this paper
• A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus.

  2008cited by this paper
• Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases

  2008cited by this paper
• A Novel Type I IFN-Producing Cell Subset in Murine Lupus1

  2008cited by this paper
• An IFN-associated cytotoxic cellular immune response against viral, self-, or tumor antigens is a common pathogenetic feature in "interface dermatitis".

  2008cited by this paper
• The type I IFN induction pathway constrains Th17-mediated autoimmune inflammation in mice.

  2008cited by this paper
• The innate immune system in SLE: type I interferons and dendritic cells

  2008cited by this paper
• Trex1 prevents cell-intrinsic initiation of autoimmunity.

  2008cited by this paper
• Treatment of lupus‐prone mice with a dual inhibitor of TLR7 and TLR9 leads to reduction of autoantibody production and amelioration of disease symptoms

  2007cited by this paper
• Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 are associated with systemic lupus erythematosus

  2007cited by this paper
• Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide

  2007cited by this paper
• Toll-like receptor 9–dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE

  2007cited by this paper
• Functional amyloid--from bacteria to humans.

  2007cited by this paper
• Dendritic Cell Apoptosis in the Maintenance of Immune Tolerance

  2006cited by this paper
• Discriminating Microbe from Self Suffers a Double Toll

  2006cited by this paper
• Genomic view of systemic autoimmunity in MRLlpr mice

  2006cited by this paper
• Type I interferon in systemic lupus erythematosus and other autoimmune diseases.

  2006cited by this paper
• Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 cause Aicardi-Goutières syndrome at the AGS1 locus

  2006cited by this paper
• Orphanet Journal of Rare Diseases BioMed Central Review

  2006cited by this paper
• Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren's syndrome.

  2006cited by this paper
• High Mobility Group B1 Protein Suppresses the Human Plasmacytoid Dendritic Cell Response to TLR9 Agonists1

  2006cited by this paper
• Cross-regulation of TNF and IFN-¿ in autoimmune diseases

  2005cited by this paper
• Cross-regulation of TNF and IFN-alpha in autoimmune diseases.

  2005cited by this paper

• Type I Interferons Induce CD8+ T Cell Chemotaxis Through Regulating Melanocyte but Not Keratinocyte CXCL9/10/11 Secretion in the Initiation of Vitiligo

  2026cites this paper
• The Role of Type I Interferons in Tuberculosis and in Tuberculosis-Risk-Associated Comorbidities

  2025cites this paper
• Determining IFI44 as a key lupus nephritis’s biomarker through bioinformatics and immunohistochemistry

  2025cites this paper
• Single-cell transcriptional landscape of peripheral myeloid cells in autoimmune diseases

  2025cites this paper
• Identification of Shared Biomarkers in Chronic Kidney Disease and Diabetic Nephropathy Using Single-Cell Sequencing

  2025cites this paper
• Type I Interferons in Systemic Autoimmune Rheumatic Diseases: Pathogenesis, Clinical Features and Treatment Options

  2024cites this paper
• IRF5 Controls Plasma Cell Generation and Antibody Production via Distinct Mechanisms Depending on the Antigenic Trigger

  2024cites this paper
• Mitochondrial Dysfunction in Systemic Lupus Erythematosus: Insights and Therapeutic Potential

  2024cites this paper
• Lymphoid origin of intrinsically activated plasmacytoid dendritic cells in mice

  2024cites this paper
• SARS-CoV-2 spike protein promotes inflammatory cytokine activation and aggravates rheumatoid arthritis

  2023cites this paper
• Progress in understanding the role of cGAS-STING pathway associated with programmed cell death in intervertebral disc degeneration

  2023cites this paper
• Neutrophils in STAT1 Gain-Of-Function Have a Pro-inflammatory Signature Which Is Not Rescued by JAK Inhibition

  2023cites this paper
• Lactobacillus acidophilus and propionate attenuate Sjögren’s syndrome by modulating the STIM1-STING signaling pathway

  2023cites this paper
• Systemic interferon type I and B cell responses are impaired in autoimmune polyendocrine syndrome type 1

  2023cites this paper
• A comprehensive review of adverse events to drugs used in COVID‐19 patients: Recent clinical evidence

  2022cites this paper
• Case Report: Interferon-Alpha-Induced Neuromyelitis Optica Spectrum Disorder

  2022cites this paper
• Interactions between the NLRP3-Dependent IL-1β and the Type I Interferon Pathways in Human Plasmacytoid Dendritic Cells

  2022cites this paper
• Type I interferons as key players in pancreatic β-cell dysfunction in type 1 diabetes.

  2021cites this paper
• Plasmacytoid dendritic cells promote the pathogenesis of Sjögren's syndrome.

  2021cites this paper
• The Complexity of the cGAS-STING Pathway in CNS Pathologies

  2021cites this paper
• Depleting plasmacytoid dendritic cells reduces local type I interferon responses and disease activity in patients with cutaneous lupus

  2021cites this paper
• Drugs That Induce or Cause Deterioration of Myasthenia Gravis: An Update

  2021cites this paper
• SLE: Novel Postulates for Therapeutic Options

  2020cites this paper
• Chylomicronemia from GPIHBP1 autoantibodies

  2020cites this paper
• Biological and clinical significance of T helper 17 cell deficiency: insight into monogenic defects.

  2020cites this paper
• Regulation of Transcription Factor E2-2 in Human Plasmacytoid Dendritic Cells by Monocyte-Derived TNFα

  2020cites this paper
• Type I interferon response drives neuroinflammation and synapse loss in Alzheimer disease.

  2020cites this paper
• Chylomicronemia from GPIHBP1 autoantibodies

  2020cites this paper
• Autoimmunity gene IRGM suppresses cGAS‐STING and RIG‐I‐MAVS signaling to control interferon response

  2020cites this paper
• Induction of Vogt-Koyanagi-Harada Disease by Interferon-Alpha and Ribavirin Treatment in Patients with Hepatitis C: A Case Report and Review of the Literature

  2019cites this paper
• mTOR inhibitor INK128 attenuates systemic lupus erythematosus by regulating inflammation-induced CD11b+Gr1+ cells.

  2019cites this paper
• GPIHBP1 autoantibody syndrome during interferon β1a treatment.

  2019cites this paper
• Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection

  2019cites this paper
• An emerging role for calcium signalling in innate and autoimmunity via the cGAS-STING axis.

  2019cites this paper
• GPIHBP1 and Lipoprotein Lipase, Partners in Plasma Triglyceride Metabolism.

  2019cites this paper
• Mutations in VP0 and 2C Proteins of Duck Hepatitis A Virus Type 3 Attenuate Viral Infection and Virulence

  2019cites this paper
• Autoimmunity Risk Gene IRGM is a Master Negative Regulator of Interferon Response by Controlling the Activation of cGAS-STING and RIG-I-MAVS Signaling Pathways

  2019cites this paper
• Orchestration of an Immune Response to Respiratory Pathogens

  2019influential citation
• Lymphoid origin of intrinsically activated plasmacytoid dendritic cells in mice

  2018cites this paper
• mRNA therapeutics deliver a hopeful message

  2018cites this paper
• Pathogen Recognition by CD4 Effectors Drives Key Effector and Most Memory Cell Generation Against Respiratory Virus

  2018cites this paper
• Vitamin D and Anti-Phospholipid Antibody Syndrome: A Comprehensive Review

  2018cites this paper
• MiR-221 negatively regulates innate anti-viral response

  2018cites this paper
• Report of the inaugural Interferon Research Summit: interferon in inflammatory diseases

  2018cites this paper
• Breaking self‐tolerance during autoimmunity and cancer immunity: Myeloid cells and type I IFN response regulation

  2018cites this paper
• The glial cell line-derived neurotrophic factor family in airway infectious disease

  2018cites this paper
• Interferon Lambda Genetics and Biology in Regulation of Viral Control

  2017cites this paper
• A Rare Case of Aicardi-Goutières Syndrome Who Showed a Positive Evolution after Being Treated with Growth Hormone, High Doses of Melatonin and Neurorehabilitation

  2017cites this paper
• Balancing anti-viral innate immunity and immune homeostasis

  2017cites this paper
• Plasmacytoid dendritic cells in autoimmunity.

  2017cites this paper
• Type I Interferon Is a Catastrophic Feature of the Diabetic Islet Microenvironment

  2017cites this paper
• Regulation of Epithelial Turnover by Host-Virome Interactions

  2016cites this paper
• Ciblage de l'activité de l'interféron alpha : de la preuve de concept à l'activité biologique

  2016cites this paper
• Protective coding variants in CFH and PELI3 and a variant near CTRB1 are associated with age-related macular degeneration

  2015cites this paper
• Interferons in Autoimmune Diseases: Friend or Foe

  2015cites this paper
• Type I IFN--a blunt spear in fighting HIV-1 infection.

  2015cites this paper
• Type I interferons link viral infection to enhanced epithelial turnover and repair.

  2015cites this paper
• High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

  2015cites this paper
• Predominant Role of Plasmacytoid Dendritic Cells in Stimulating Systemic Autoimmunity

  2015cites this paper
• Pivotal Functions of Plasmacytoid Dendritic Cells in Systemic Autoimmune Pathogenesis

  2014cites this paper
• Harnessing Mechanistic Knowledge on Beneficial Versus Deleterious IFN-I Effects to Design Innovative Immunotherapies Targeting Cytokine Activity to Specific Cell Types

  2014influential citation
• Transient decrease in human peripheral blood myeloid dendritic cells following influenza vaccination correlates with induction of serum antibody

  2014cites this paper
• TLRs and interferons: a central paradigm in autoimmunity.

  2013cites this paper